Important NoticeThis app is for educational purposes only. You must be 18+ to use it. We do not sell any peptides on this site.

Peptide Library / Detail
Half-life
Not established in published literature
Delivery
Subcutaneous or intramuscular injection
Dosage
—
Research Use Only
All products listed are for laboratory research only — not for human consumption. By browsing, you acknowledge these terms.
Bronchogen is a short synthetic tetrapeptide with the sequence Ala-Asp-Glu-Leu (ADEL) that acts as a biological regulator with specific affinity for bronchial and lung tissue. It belongs to a class of tissue-specific peptides that modulate gene expression and cellular differentiation. Research suggests it exerts protective and regenerative effects on bronchial epithelium, particularly in models of obstructive lung pathology.
Bronchogen is administered in research settings typically via subcutaneous or intramuscular injection. Studies have examined dosing protocols ranging from 10-100 μg per administration over periods of 10-30 days. The peptide has been studied primarily in animal models of chronic obstructive pulmonary conditions with administration once daily during active treatment phases.
Bronchogen penetrates cell nuclei and interacts directly with DNA and deoxyribooligonucleotides, affecting DNA thermostability and modulating gene expression. It tissue-specifically regulates expression of CLE, KNOX1, and GRF family genes involved in cellular differentiation and tissue homeostasis. The peptide demonstrates anti-inflammatory properties and promotes morphofunctional restoration of bronchial epithelium by stimulating cell differentiation processes, particularly during aging or pathological conditions.
Bronchogen is a short synthetic tetrapeptide with the sequence Ala-Asp-Glu-Leu (ADEL) that acts as a biological regulator with specific affinity for bronchial and lung tissue. It belongs to a class of tissue-specific peptides that modulate gene expression and cellular differentiation. Research suggests it exerts protective and regenerative effects on bronchial epithelium, particularly in models of obstructive lung pathology.
Bronchogen has an approximate half-life of Not established in published literature. The half-life determines how often you need to inject to maintain steady blood levels — use the Peptides Calculator half-life calculator to plot your specific dosing schedule and see the decay curve.
Bronchogen is typically delivered via subcutaneous or intramuscular injection. The Peptides Calculator app helps you reconstitute the vial with bacteriostatic water, calculate your exact dose in syringe units, and track each injection.
Bronchogen penetrates cell nuclei and interacts directly with DNA and deoxyribooligonucleotides, affecting DNA thermostability and modulating gene expression. It tissue-specifically regulates expression of CLE, KNOX1, and GRF family genes involved in cellular differentiation and tissue homeostasis. The peptide demonstrates anti-inflammatory properties and promotes morphofunctional restoration of bronchial epithelium by stimulating cell differentiation processes, particularly during aging or pathological conditions.
Studied benefits of Bronchogen include: Promotes regeneration and repair of bronchial epithelium, Reduces inflammatory responses in lung tissue, Improves morphofunctional state of airways in obstructive pathology, Modulates tissue-specific gene expression related to cellular differentiation, Enhances DNA stability in bronchial cells, Supports cellular differentiation during aging processes, Demonstrates tissue-specific targeting to pulmonary structures. These are research findings only — Peptides Calculator does not provide medical advice; consult a qualified healthcare professional before starting any peptide protocol.
Reported side effects of Bronchogen include: Limited human safety data available, Potential injection site reactions, Unknown long-term effects in humans, Possible immunogenic responses (theoretical), Effects on non-target tissues not fully characterized. Always discuss potential side effects with a licensed healthcare provider before using any research peptide.
Other recovery compounds in the Peptides Calculator library.
Half-life · Approximately 1-2 hours (estimated based on similar short peptides)
Half-life · Not extensively characterized; short peptides typically have half-lives of minutes to hours
Half-life · Approximately 30-60 minutes (varies by delivery method and formulation)
Half-life · Estimated 1-3 hours (typical for short tripeptides)
Half-life · 30-60 minutes
Half-life · Approximately 2-3 hours